haloperidol has been researched along with physostigmine in 96 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 70 (72.92) | 18.7374 |
| 1990's | 12 (12.50) | 18.2507 |
| 2000's | 8 (8.33) | 29.6817 |
| 2010's | 6 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, G; Ermondi, G | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Asper, H; Bürki, HR; Ruch, W; Sayers, AC | 1 |
| Varipapa, RJ | 1 |
| Carroll, BJ; Curtis, GC; Kokmen, E | 1 |
| Chan, SH | 1 |
| Lassen, JB | 1 |
| Maeno, H; Sano, K; Usuda, S | 1 |
| Bloss, JL; Singer, GH | 1 |
| Anisman, H; Remington, G; Sklar, LS | 1 |
| Korf, J; Westerink, BH | 1 |
| Kuran, W | 1 |
| Avanzini, G; Caraceni, T; Giovannini, P; Girotti, F | 1 |
| Battista, AF; Goldstein, M; Miyamoto, T | 1 |
| Carolei, A; Margotta, V; Palladini, G | 1 |
| Bouyer, JJ; Joseph, JP; Rougeul, A | 1 |
| Lai, C; Tolosa, ES | 1 |
| Anlezark, GM; Marsden, CD; Meldrum, BS | 1 |
| Kato, R; Muraki, T; Nakadate, T; Tokunaga, Y | 1 |
| Fink, H; Oelssner, W | 1 |
| Extein, I | 1 |
| Delanoy, RL; Dunn, AJ; Tintner, R | 1 |
| Carlson, KR; Eibergen, RD | 2 |
| Cavalheiro, EA; Izquierdo, I | 1 |
| Berger, PA; Davis, KL; De Fraites, EG | 1 |
| Dunstan, R; Jackson, DM | 1 |
| Holmgren, B; Urbá-Holmgren, R; Valdés, M | 1 |
| Baldessarini, RJ; Granacher, RP | 1 |
| Hussey, HH | 1 |
| Fujiwara, M; Ibii, N; Inoue, K; Kataoka, Y; Ueki, S | 1 |
| Neill, DB | 1 |
| Poddar, MK; Ray, SK | 1 |
| Chapman, MA; See, RE | 1 |
| el-Sawaf, HA; Puri, VN; Rao, KV | 1 |
| Furukawa, T; Yamada, K | 1 |
| Kovalev, GV; Kuleshova, IP; Sazhin, VA | 1 |
| Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ; Tye, SJ | 1 |
| Inanaga, K; Kojima, H; Nishi, S; Tsutsumi, T; Yamada, S; Yokoo, H | 1 |
| Marien, MR; Richard, JW | 1 |
| Emilien, G | 1 |
| Bakshi, VP; Delfs, JM; Kelley, AE; Lang, CG | 1 |
| Barclay, AM | 1 |
| Jenner, P; Marsden, CD; Rupniak, NM | 1 |
| Hashizume, K; Manaka, S; Sasaki, M; Takakura, K | 1 |
| Bowman, RE; Levin, ED; Vuchetich, J; Wegert, S | 1 |
| Cubeddu, LX; James, MK | 1 |
| Furukawa, T; Imaizumi, J; Mizuki, Y; Noda, Y; Ushijima, I; Yamada, K; Yamada, M | 1 |
| Haraguchi, H; Kuribara, H; Tadokoro, S | 1 |
| Carman, JS | 1 |
| Carlsson, A; Kehr, W; Lindqvist, M | 1 |
| Davis, JM | 1 |
| Consolo, S; Garattini, S; Ladinsky, H; Peri, G | 1 |
| Bhatnagar, SP | 1 |
| Cheng, HC; Long, JP | 1 |
| Fjalland, B; Moller Nielsen, I | 1 |
| Ishida, R; Kojima, M; Kowa, Y; Nose, T; Shintomi, K | 1 |
| Consroe, PF; White, RP | 1 |
| Ueda, S | 1 |
| Al-Shabibi, UM; Doggett, NS | 1 |
| Freed, WJ; Luchins, DJ; Wyatt, RJ | 1 |
| Miczek, KA; Yoshimura, H | 1 |
| Berger, PA; Stahl, SM | 1 |
| Mizuki, Y; Noda, Y; Ushijima, I; Yamada, M | 1 |
| Forsythe, WI; Gillies, DR | 1 |
| Eyzaguirre, C; Ito, H | 1 |
| Cohen, DJ; Leckman, JF | 1 |
| Furukawa, T; Ushijima, I; Yamada, K | 1 |
| Hartgraves, SL; Kelly, PH | 1 |
| Agnoli, A; Chase, TN; Denaro, A; Ruggieri, S; Tamminga, CA | 1 |
| Jones, RS; Olpe, HR; Steinmann, MW | 1 |
| Meck, WH | 1 |
| Delashaw, JB; Dement, WC; Foutz, AS; Guilleminault, C | 1 |
| Adams, PM; Castellani, S; Giannini, AJ | 1 |
| Millington, WR; Wurtman, RJ | 1 |
| Adams, PM; Boeringa, JA; Castellani, S; Giannini, AJ | 1 |
| de la Garza, R; Johanson, CE | 1 |
| Demieville, H; Glatt, A; Olpe, HR; Santucci, V | 1 |
| Egbe, PC; Wray, SR | 1 |
| Dysken, MW; Goetz, CG; Klawans, HL | 1 |
| Kameyama, T; Kobayashi, T; Ukai, M | 1 |
| Shenoy, RS | 1 |
| Buhusi, CV; Schmajuk, NA | 1 |
| Hirano, H; Kaneyuki, H; Kawano, M; Mizuki, Y; Suetsugi, M; Usami, K; Ushijima, I; Yamada, M | 1 |
| Kurasawa, M; Nakamura, K | 1 |
| Nagura, H | 1 |
| Arya, P; Butler, R; Warner, J | 1 |
| Barak, S; Weiner, I | 1 |
| Arai, M; Arikawa-Hirasawa, E; Arinami, T; Horiuchi, Y; Inada, T; Iritani, S; Ishiguro, H; Ishikawa, M; Itokawa, M; Kakita, A; Keino-Masu, K; Nawa, H; Niizato, K; Ozaki, N; Syu, A; Takahashi, H; Takahashi, M; Tanaka, S | 1 |
6 review(s) available for haloperidol and physostigmine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Acute dystonia induced by neuroleptic drugs.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Brain; Chlorpromazine; Disease Models, Animal; Drug Synergism; Dystonia; Fluphenazine; Haloperidol; Histamine H1 Antagonists; Levodopa; Mastication; Methyltyrosines; Movement Disorders; Parasympatholytics; Physostigmine; Primates; Rats | 1986 |
Treatment of multiple tics and the Tourette syndrome.
Topics: Adolescent; Antipsychotic Agents; Benztropine; Child; Child, Preschool; Clonidine; Haloperidol; Humans; Phenothiazines; Physostigmine; Pimozide; Tic Disorders; Tourette Syndrome | 1984 |
Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.
Topics: Adolescent; Age Factors; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Compulsive Behavior; Dopamine; Female; Haloperidol; Homovanillic Acid; Humans; Male; Obsessive Behavior; Obsessive-Compulsive Disorder; Parasympathomimetics; Physostigmine; Receptors, Adrenergic; Serotonin; Sex Factors; Tic Disorders; Tourette Syndrome | 1983 |
[Drugs for the treatment of Alzheimer's disease].
Topics: Acetylcholine; Alzheimer Disease; Antidepressive Agents; Cerebral Cortex; Cholinesterase Inhibitors; Donepezil; Haloperidol; Humans; Hydroxyzine; Hypnotics and Sedatives; Indans; Injections, Intramuscular; Physostigmine; Piperidines; Selective Serotonin Reuptake Inhibitors; Tacrine | 2004 |
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E | 2004 |
2 trial(s) available for haloperidol and physostigmine
| Article | Year |
|---|---|
Meige disease: striatal dopaminergic preponderance.
Topics: Aged; Apomorphine; Basal Ganglia; Blepharospasm; Clinical Trials as Topic; Diagnosis, Differential; Eyelid Diseases; Facial Muscles; Female; Haloperidol; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Physostigmine; Placebos | 1979 |
Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystonias.
Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Dystonia; Female; Haloperidol; Humans; Male; Middle Aged; Neurotransmitter Agents; Physostigmine; Receptors, Cholinergic; Receptors, Dopamine; Torticollis | 1982 |
88 other study(ies) available for haloperidol and physostigmine
| Article | Year |
|---|---|
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.
Topics: Animals; Antipsychotic Agents; Atropine; Basal Ganglia Diseases; Clozapine; Corpus Striatum; Drug Interactions; Dyskinesia, Drug-Induced; Female; Haloperidol; Homovanillic Acid; Male; Parasympathetic Nervous System; Physostigmine; Rats; Receptors, Dopamine; Receptors, Muscarinic | 1976 |
PCP treatment.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Haloperidol; Humans; Phencyclidine; Phenothiazines; Physostigmine | 1977 |
Paradoxical response to dopamine agonists in tardive dyskinesia.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Apomorphine; Benztropine; Clozapine; Deanol; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Levodopa; Physostigmine; Receptors, Dopamine; Reserpine; Stimulation, Chemical; Thioridazine | 1977 |
Central neurotransmitter systems in the morphine suppression of jaw-opening reflex in rabbits: the dopaminergic system.
Topics: Animals; Apomorphine; Dopamine; Dopamine Antagonists; Haloperidol; Jaw; Morphine; Neurotransmitter Agents; Pain; Physostigmine; Pimozide; Rabbits; Reflex | 1979 |
Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Clozapine; Female; Haloperidol; Injections, Intramuscular; Mice; Oxotremorine; Parasympathomimetics; Physostigmine | 1979 |
Pharmacological and biochemical studies on a new potential neuroleptic, N-(1-benzyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-08050).
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Catalepsy; Chlorpromazine; Dogs; Dopamine; Drug Interactions; Female; Haloperidol; Humans; Male; Methamphetamine; Mice; Physostigmine; Rats; Stereotyped Behavior; Synaptic Membranes | 1979 |
Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat.
Topics: Animals; Avoidance Learning; Behavior, Animal; Catalepsy; Clozapine; Dextroamphetamine; Fluphenazine; Haloperidol; Humans; Male; Mice; Motor Activity; Physostigmine; Prostaglandins E; Prostaglandins E, Synthetic; Rats; Stereotyped Behavior; Thioridazine | 1978 |
Effect of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenance.
Topics: Animals; Avoidance Learning; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain Chemistry; Dopamine; Electroshock; Female; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Norepinephrine; Parasympathetic Nervous System; Physostigmine; Scopolamine; Serotonin; Sympathetic Nervous System | 1979 |
Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain.
Topics: Aminooxyacetic Acid; Animals; Atropine; Brain; Brain Chemistry; Clozapine; Corpus Striatum; Fenclonine; Haloperidol; Homovanillic Acid; Limbic System; Male; Morphine; Oxotremorine; Phenylacetates; Physostigmine; Pimozide; Probenecid; Rats; Substantia Nigra; Trihexyphenidyl | 1975 |
[Modern methods of treating Huntington's chorea].
Topics: gamma-Aminobutyric Acid; Haloperidol; Humans; Huntington Disease; Lithium; Methysergide; Physostigmine; Tetrabenazine | 1976 |
Pharmacology of Huntington's chorea. Personal experience.
Topics: Acetates; Adult; Aminobutyrates; Blood Cell Count; Bromocriptine; Female; gamma-Aminobutyric Acid; Haloperidol; Humans; Huntington Disease; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Physostigmine; Receptors, Dopamine; Valerates; Valproic Acid | 1977 |
Modification of involuntary movements by centrally acting drugs.
Topics: Aminooxyacetic Acid; Animals; Atropine; Bicuculline; Bromocriptine; Dopamine; Haloperidol; Haplorhini; Levodopa; Movement Disorders; Physostigmine; Picrotoxin; Piperazines; Piribedil; Receptors, Drug; Synaptic Transmission; Thalamic Nuclei; Theophylline | 1975 |
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria | 1975 |
Effects of two neuroleptic drugs on focal somatoparietal rhythms in free awake cats.
Topics: Animals; Cats; Chlorpromazine; Electroencephalography; Haloperidol; Physostigmine; Sleep, REM; Wakefulness | 1979 |
Acute dystonia as an idiosyncratic response to neuroleptics in baboons.
Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Haloperidol; Haplorhini; Humans; Levodopa; Movement Disorders; Papio; Parasympatholytics; Physostigmine; Pimozide; Receptors, Dopamine; Reserpine; Syndrome; Tranquilizing Agents | 1977 |
Inhibition by cholinergic agonists of the prolactin release induced by morphine.
Topics: Animals; Atropine; Haloperidol; Male; Mecamylamine; Methyltyrosines; Morphine; Parasympathomimetics; Physostigmine; Pilocarpine; Prolactin; Rats | 1979 |
[Effect of psychotomimetics and haloperidol on head twitching following alcohol withdrawal in mice].
Topics: Animals; Ethanol; Hallucinogens; Haloperidol; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Mice; Physostigmine; Substance Withdrawal Syndrome; Tremor | 1978 |
Methylphenidate-induced choreoathetosis.
Topics: Female; Haloperidol; Humans; Methapyrilene; Methylphenidate; Middle Aged; Movement Disorders; Physostigmine; Receptors, Dopamine | 1978 |
Behavioral responses to intracerebroventricularly administered neurohypophyseal peptides in mice.
Topics: Animals; Arginine Vasopressin; Behavior, Animal; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraventricular; Lypressin; Male; Mice; Oxytocin; Physostigmine; Reserpine; Syringes | 1978 |
Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Dyskinesia, Drug-Induced; Haloperidol; Haplorhini; Humans; Macaca mulatta; Male; Methadone; Methamphetamine; Naloxone; Phenobarbital; Phentolamine; Physostigmine; Spiperone; Stereotyped Behavior | 1976 |
Three main factors in rat shuttle behavior: their pharmacology and sequential entry in operation during a two-way avoidance session.
Topics: Animals; Apomorphine; Atropine; Atropine Derivatives; Avoidance Learning; Clonidine; Conditioning, Classical; Conditioning, Operant; Drive; Female; Haloperidol; Male; Nicotine; Phenoxybenzamine; Physostigmine; Rats | 1976 |
Susceptibility to amphetamine-elicited dyskinesias following chronic methadone treatment in monkeys.
Topics: Animals; Chlorpromazine; Clozapine; Diazepam; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Haplorhini; Macaca mulatta; Male; Methadone; Methamphetamine; Phenobarbital; Phentolamine; Physostigmine; Spiperone; Time Factors | 1976 |
Coexisting tardive dyskinesia and parkinsonism: a case report.
Topics: Acetylcholine; Adult; Benztropine; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Male; Parkinson Disease, Secondary; Physostigmine; Schizophrenia, Paranoid; Thioridazine; Tranquilizing Agents | 1977 |
The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment.
Topics: Animals; Apomorphine; Atropine; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Motor Activity; Physostigmine; Premedication; Receptors, Cholinergic; Receptors, Dopamine | 1977 |
Relative role of catecholamines in head-shaking of infant rats.
Topics: Animals; Animals, Newborn; Apomorphine; Behavior; Catecholamines; Chlorpromazine; Dextroamphetamine; Drug Interactions; Female; Haloperidol; Humans; Male; Motor Activity; Phenoxybenzamine; Physostigmine; Propranolol; Rats; Stereotyped Behavior | 1976 |
Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs.
Topics: Acute Disease; Adult; Amitriptyline; Benztropine; Chemical Phenomena; Chemistry; Cholinesterase Inhibitors; Doxepin; Female; Haloperidol; Humans; Male; Nervous System Diseases; Parasympatholytics; Physostigmine; Psychoses, Substance-Induced; Syndrome; Thioridazine | 1975 |
Editorial: Physostigmine: value in treatment of central toxic effects of anti-cholinergic drugs.
Topics: Amitriptyline; Benztropine; Brain; Doxepin; Haloperidol; Humans; Injections, Intramuscular; Mental Disorders; Parasympatholytics; Physostigmine; Thioridazine | 1975 |
[Behavior pharmacology of maprotiline, a new antidepressant].
Topics: Aggression; Amitriptyline; Animals; Anthracenes; Apomorphine; Behavior, Animal; Body Temperature; Catalepsy; Escape Reaction; Eyelids; Haloperidol; Humans; Imipramine; Levodopa; Maprotiline; Methamphetamine; Mice; Motor Activity; Oxotremorine; Physostigmine; Rats; Reserpine; Sleep; Tetrabenazine | 1975 |
Frontal-striatal control of behavioral inhibition in the rat.
Topics: Animals; Behavior, Animal; Corpus Striatum; Dextroamphetamine; Dopamine; Frontal Lobe; Haloperidol; Male; Neural Inhibition; Neural Pathways; Norepinephrine; Physostigmine; Rats; Scopolamine; Stimulation, Chemical | 1976 |
Interaction of central serotonin and dopamine in the regulation of carbaryl-induced tremor.
Topics: 5-Hydroxytryptophan; Acetylcholinesterase; Animals; Atropine; Behavior, Animal; Brain Chemistry; Bromocriptine; Carbaryl; Corpus Striatum; Dopamine; Haloperidol; Hydroxyindoleacetic Acid; Male; Methysergide; Physostigmine; Rats; Serotonin; Tremor | 1990 |
Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Fourier Analysis; Haloperidol; Male; Mouth; Movement; Oxotremorine; Parasympathetic Nervous System; Parasympathomimetics; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Scopolamine | 1991 |
Further studies on the neuroleptic profile of manassantin A.
Topics: Adenylyl Cyclase Inhibitors; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Binding, Competitive; Blepharoptosis; Body Temperature; Catalepsy; Furans; Haloperidol; In Vitro Techniques; Levodopa; Lignans; Male; Mice; Norepinephrine; Pentobarbital; Physostigmine; Plants, Medicinal; Stereotyped Behavior | 1990 |
[Behavioral effects of a new antidepressant, setiptiline].
Topics: 5-Hydroxytryptophan; Amitriptyline; Animals; Antidepressive Agents; Body Temperature; Catalepsy; Drug Synergism; Haloperidol; Male; Methamphetamine; Mianserin; Mice; Motor Activity; Physostigmine; Promethazine; Rats; Rats, Inbred Strains; Yawning | 1991 |
[Pharmacological correction of ketamine-impaired spatial memory of rats].
Topics: Amnesia; Animals; Aspartic Acid; Haloperidol; Hippocampus; Ketamine; Memory, Short-Term; Physostigmine; Rats; Spatial Behavior | 1990 |
Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: implications for tardive dyskinesia.
Topics: Animals; Benzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Facial Expression; Facial Muscles; Haloperidol; Macaca fascicularis; Mastication; Movement Disorders; Physostigmine; Scopolamine; Stereotyped Behavior | 1990 |
Involvement of the cholinergic system in haloperidol-induced release of dopamine from slices of striatum in the rat.
Topics: Acetylcholine; Animals; Atropine; Corpus Striatum; Dopamine; Haloperidol; In Vitro Techniques; Male; Nerve Endings; Nerve Tissue Proteins; Parasympathetic Nervous System; Physostigmine; Rats; Rats, Inbred Strains; Tetrodotoxin | 1990 |
Drug effects on the release of endogenous acetylcholine in vivo: measurement by intracerebral dialysis and gas chromatography-mass spectrometry.
Topics: Acetylcholine; Animals; Atropine; Chromatography, Gas; Consciousness; Corpus Striatum; Dialysis; Haloperidol; Magnesium; Male; Mass Spectrometry; Phencyclidine; Physostigmine; Piperidines; Potassium; Rats; Rats, Inbred Strains; Tetrodotoxin | 1990 |
Effect of drugs acting on monoaminergic and cholinergic systems on the quantified EEG of rats.
Topics: Animals; Cerebral Cortex; Clonidine; Dose-Response Relationship, Drug; Electroencephalography; Evoked Potentials; Haloperidol; Locus Coeruleus; Male; Physostigmine; Piracetam; Psychotropic Drugs; Rats; Receptors, Adrenergic, alpha; Receptors, Cholinergic; Yohimbine | 1989 |
Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity.
Topics: Acetylcholine; Animals; Atropine; Corpus Striatum; Dose-Response Relationship, Drug; Haloperidol; Male; Mouth; Movement; Parasympathetic Nervous System; Physostigmine; Rats; Rats, Inbred Strains | 1989 |
Psychotropic drugs in the elderly. Selection of the appropriate agent.
Topics: Age Factors; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Chlordiazepoxide; Cimetidine; Diazepam; Flurazepam; Haloperidol; Humans; Kinetics; Lithium; Phenothiazines; Physostigmine; Psychotropic Drugs; Thiothixene; Trazodone | 1985 |
[The influences of neurotransmitters on the traumatic unconsciousness, immediate convulsion and mortality in the experimental mice model].
Topics: Animals; Atropine; Craniocerebral Trauma; Disease Models, Animal; Haloperidol; Male; Methamphetamine; Mice; Neurotransmitter Agents; Physostigmine; Scopolamine; Seizures; Unconsciousness | 1987 |
Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys.
Topics: Acetylcholine; Amphetamine; Animals; Behavior, Animal; Cognition Disorders; Dopamine; Haloperidol; Lead Poisoning; Levodopa; Macaca mulatta; Physostigmine; Scopolamine; Sulpiride | 1987 |
Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
Topics: Acetylcholine; Animals; Atropine; Carbachol; Corpus Striatum; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Oxotremorine; Physostigmine; Pirenzepine; Quinuclidinyl Benzilate; Rabbits; Receptors, Muscarinic; Scopolamine; Time Factors | 1987 |
Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
Topics: Animals; Apomorphine; Behavior, Animal; Haloperidol; Male; Mecamylamine; N-Methylscopolamine; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Scopolamine; Scopolamine Derivatives; Time Factors | 1985 |
Comparisons between discrete lever-press and shuttle avoidance responses in mice: acquisition processes and effects of psychoactive drugs.
Topics: Animals; Atropine; Avoidance Learning; Chlorpromazine; Conditioning, Operant; Dose-Response Relationship, Drug; Haloperidol; Male; Methamphetamine; Mice; Mice, Inbred Strains; Physostigmine; Pilocarpine; Psychotropic Drugs | 1985 |
Hyperdopaminergic states: a continuum.
Topics: Dihydroxyphenylalanine; Haloperidol; Humans; Obsessive-Compulsive Disorder; Physostigmine; Tryptophan | 1972 |
Short-term control of tyrosine hydroxylase.
Topics: Adrenal Medulla; Animals; Apomorphine; Atropine; Axons; Brain; Chlorisondamine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Epinephrine; Haloperidol; Monoamine Oxidase Inhibitors; Norepinephrine; Pargyline; Phentolamine; Physostigmine; Rats; Time Factors; Tyrosine 3-Monooxygenase | 1974 |
Psychopharmacology in the aged. Use of psychotropic drugs in geriatric patients.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Chlorpromazine; Depression; Dihydroergotoxine; Drug Interactions; Electroconvulsive Therapy; Gonadal Steroid Hormones; Guanethidine; Haloperidol; Humans; Lithium; Mental Disorders; Physostigmine; Psychotropic Drugs; Schizophrenia; Thiothixene; Thioxanthenes; Vitamins | 1974 |
Effect of central stimulants and depressants on mouse brain acetylcholine and choline levels.
Topics: Acetylcholine; Amphetamine; Animals; Atropine; Brain Chemistry; Central Nervous System Stimulants; Chlorpromazine; Choline; Depression, Chemical; Desipramine; Diazepam; Haloperidol; Ketones; Male; Mice; Pentobarbital; Pentylenetetrazole; Physostigmine; Reserpine; Stimulation, Chemical; Tranquilizing Agents; Tremorine | 1972 |
Studies related to the cholinergic influence on the accumulation and disappearance of monoamines in rat brain.
Topics: Animals; Atropine; Biogenic Amines; Brain; Carbon Radioisotopes; Choline; Dopamine; Female; Haloperidol; Hemicholinium 3; Methyltyrosines; Norepinephrine; Parasympathetic Nervous System; Pargyline; Physostigmine; Rats; Reserpine; Serotonin; Spectrometry, Fluorescence | 1973 |
Dopaminergic nature of apomorphine-induced pecking in pigeons.
Topics: Animals; Apomorphine; Aporphines; Behavior, Animal; Chlorpromazine; Columbidae; Dihydroxyphenylalanine; Dioxoles; Dopamine; Haloperidol; Imipramine; Methyltyrosines; Nicotine; Oxotremorine; Phentolamine; Physostigmine; Pilocarpine; Propranolol; Receptors, Drug; Reserpine; Serotonin; Time Factors | 1974 |
Methylphenidate antagonism of haloperidol, interaction with cholinergic and anticholinergic drugs.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Germ-Free Life; Haloperidol; Humans; Male; Methylphenidate; Mice; Physostigmine; Scopolamine; Statistics as Topic; Stereotyped Behavior; Time Factors | 1974 |
[Pharmacological properties of 6,6,9-trimethyl-9-azabicyclo (3,3,1)non-3 beta-yl-alpha, alpha-di(2-thienyl) glycolate hydrochloride monohydrate (PG-501), a new anti-parkinsonian agent].
Topics: Acetylcholine; Analgesics; Anesthetics, Local; Animals; Anticonvulsants; Barbiturates; Behavior, Animal; Blood Pressure; Body Temperature; Cats; Depression, Chemical; Drug Synergism; Electroencephalography; Gastrointestinal Motility; Glycolates; Guinea Pigs; Haloperidol; Haplorhini; Heterocyclic Compounds; In Vitro Techniques; Male; Mice; Neuromuscular Junction; Nictitating Membrane; Parasympatholytics; Parkinson Disease, Secondary; Physostigmine; Pupil; Rabbits; Reserpine; Respiration; Salivation; Thiophenes; Tremor; Tremorine | 1971 |
Effects of haloperidol and chlorpromazine on central adrenergic and cholinergic mechanisms in rabbits.
Topics: Acoustic Stimulation; Animals; Behavior, Animal; Blood Pressure; Body Temperature; Cerebral Cortex; Chlorpromazine; Citrates; Electrodes, Implanted; Electroencephalography; Female; Haloperidol; Male; Methamphetamine; Motor Activity; Parasympathetic Nervous System; Physostigmine; Pupil; Rabbits; Respiration; Stimulation, Chemical; Sympathetic Nervous System | 1972 |
[Pharmacological responses of the pyloric antrum strip of the rat stomach, with special reference to the mechanism of the contractions caused by serotonin and nicotine, relaxation of transmural stimulation and contraction and relaxation by tyramine].
Topics: Acetylcholine; Animals; Atropine; Barium; Bretylium Compounds; Cocaine; Depression, Chemical; Dibenzylchlorethamine; Haloperidol; In Vitro Techniques; Methysergide; Morphine; Muscle Contraction; Nicotine; Phenoxybenzamine; Physostigmine; Procaine; Propranolol; Pylorus; Rats; Receptors, Drug; Scopolamine; Serotonin; Stimulation, Chemical; Tyramine | 1971 |
Clozapine's anti-acetylcholine property modulates its antistereotypic action in the mesolimbic system.
Topics: Acetylcholine; Animals; Behavior; Clozapine; Dextroamphetamine; Dibenzazepines; Electric Stimulation; Electrodes, Implanted; Haloperidol; Humans; Limbic System; Male; Oxotremorine; Physostigmine; Rats; Stereotyped Behavior | 1980 |
The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs.
Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Mice; Physostigmine; Receptors, Cholinergic; Receptors, Muscarinic; Seizures; Substance Withdrawal Syndrome | 1980 |
Disruption of primate social behavior by d-amphetamine and cocaine: differential antagonism by antipsychotics.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Cocaine; Dextroamphetamine; Haloperidol; Humans; Male; Motor Activity; Physostigmine; Saimiri; Social Behavior; Stereotyped Behavior | 1982 |
Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Haloperidol; Humans; Male; Parasympathomimetics; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Dopamine; Scopolamine; Stereotyped Behavior | 1984 |
Effects of temperature on the response of chemoreceptor fibers to chemical agents.
Topics: Acetylcholine; Animals; Body Temperature; Calcium; Carotid Body; Cats; Dopamine; Haloperidol; Mecamylamine; Nerve Fibers; Physostigmine; Sodium Cyanide; Synaptic Transmission | 1983 |
Acute and long-term effects of thyrotropin releasing hormone on behavior mediated by dopaminergic and cholinergic activities in mice.
Topics: Animals; Atropine; Atropine Derivatives; Behavior, Animal; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Mice; Parasympathetic Nervous System; Physostigmine; Receptors, Dopamine; Salivation; Stereotyped Behavior; Thyrotropin-Releasing Hormone; Time Factors; Tremor | 1984 |
Role of mesencephalic reticular formation in cholinergic-induced catalepsy and anticholinergic reversal of neuroleptic-induced catalepsy.
Topics: Acetylcholine; Animals; Atropine; Catalepsy; Caudate Nucleus; Cholinergic Fibers; Haloperidol; Humans; Male; Mesencephalon; Nucleus Accumbens; Physostigmine; Rats; Rats, Inbred Strains; Reticular Formation; Scopolamine | 1984 |
State of DA/ACh balance after chronic treatment with haloperidol and with THIP in rats.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Behavior, Animal; Brain; Dopamine; Haloperidol; Isoxazoles; Male; Oxazoles; Physostigmine; Rats; Rats, Inbred Strains | 1984 |
The locus coeruleus: actions of psychoactive drugs.
Topics: Action Potentials; Animals; Atropine; Caffeine; Chlorpromazine; Desipramine; Haloperidol; Locus Coeruleus; Male; Neurons; Nicotine; Norepinephrine; Physostigmine; Psychotropic Drugs; Rats; Scopolamine | 1983 |
Selective adjustment of the speed of internal clock and memory processes.
Topics: Animals; Atropine; Discrimination Learning; Electroshock; Haloperidol; Male; Memory; Mental Recall; Methamphetamine; Oxytocin; Physostigmine; Rats; Time Perception; Vasopressins | 1983 |
Monoaminergic mechanisms and experimental cataplexy.
Topics: Animals; Antidepressive Agents, Tricyclic; Biogenic Amines; Cataplexy; Dogs; Female; Fluoxetine; Haloperidol; Humans; Male; Methylphenidate; Monoamine Oxidase Inhibitors; Physostigmine; Pimozide; Propranolol; Sleep, REM; Sodium Oxybate | 1981 |
Physostigmine and haloperidol treatment of acute phencyclidine intoxication.
Topics: Acute Disease; Adolescent; Adult; Female; Haloperidol; Humans; Male; Phencyclidine Abuse; Physostigmine; Psychiatric Status Rating Scales | 1982 |
Choline and physostigmine enhance haloperidol-induced HVA and DOPAC accumulation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Choline; Corpus Striatum; Drug Synergism; Haloperidol; Homovanillic Acid; Male; Phenylacetates; Physostigmine; Rats; Rats, Inbred Strains | 1982 |
Phencyclidine intoxication: assessment of possible antidotes.
Topics: Antidotes; Haloperidol; Humans; Meperidine; Phencyclidine; Physostigmine | 1982 |
Effects of haloperidol and physostigmine on self-administration of local anesthetics.
Topics: Animals; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Female; Haloperidol; Macaca mulatta; Male; Physostigmine; Procaine; Receptors, Cholinergic; Reinforcement Schedule; Self Administration | 1982 |
Quantification of slow-wave EEG induced by atropine: effects of physostigmine, amphetamine and haloperidol.
Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Electroencephalography; Haloperidol; Male; Physostigmine; Rats | 1981 |
Effects of reserpine, tranylcypromine, haloperidol and FLA-63 on physostigmine--induced hyperactivity in rats.
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Female; Haloperidol; Imidazoles; Motor Activity; Physostigmine; Rats; Reserpine; Tranylcypromine | 1980 |
Assessment and treatment of drug-induced tremor.
Topics: Aged; Benztropine; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Paranoid Disorders; Physostigmine | 1980 |
Characterization of the effects of scopolamine on the habituation of exploratory activity: differential effects of oxotremorine and physostigmine.
Topics: Amnesia; Animals; Exploratory Behavior; Habituation, Psychophysiologic; Haloperidol; Learning; Male; Mice; Mice, Inbred Strains; Motor Activity; Oxotremorine; Physostigmine; Receptors, Muscarinic; Retention, Psychology; Scopolamine | 1994 |
Pitfalls in the treatment of jimsonweed intoxication.
Topics: Adolescent; Contraindications; Datura stramonium; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Male; Physostigmine; Plants, Medicinal; Plants, Toxic; Psychoses, Substance-Induced; Substance-Related Disorders | 1994 |
Attention, configuration, and hippocampal function.
Topics: Animals; Attention; Cerebellum; Computer Simulation; Conditioning, Psychological; Dopamine Antagonists; Entorhinal Cortex; Evaluation Studies as Topic; Haloperidol; Hippocampus; Long-Term Potentiation; Maze Learning; Models, Neurological; Neural Inhibition; Parasympathomimetics; Physostigmine; Septal Nuclei; Space Perception; Spatial Behavior | 1996 |
Dopaminergic and cholinergic interaction in cataleptic responses in mice.
Topics: Animals; Apomorphine; Benzazepines; Catalepsy; Cholinergic Antagonists; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Mice; Mice, Inbred Strains; Parasympathetic Nervous System; Parasympathomimetics; Physostigmine; Pilocarpine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Muscarinic; Scopolamine | 1997 |
Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Bromocriptine; Diazepam; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Fear; Fluvoxamine; Haloperidol; Indophenol; Male; Maze Learning; Mecamylamine; Mice; Mice, Inbred ICR; Moclobemide; Motor Activity; Nicotine; Nicotinic Antagonists; Nortriptyline; Physostigmine; Picolinic Acids; Pyrrolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Social Behavior; Stress, Psychological | 2001 |
Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Attention; Cholinergic Antagonists; Clozapine; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking Behavior; Glycine; Haloperidol; Inhibition, Psychological; Male; Physostigmine; Rats; Rats, Wistar; Schizophrenia; Scopolamine | 2009 |
Association of the HSPG2 gene with neuroleptic-induced tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Cholinesterase Inhibitors; Dyskinesia, Drug-Induced; Female; Genetic Association Studies; Haloperidol; Heparan Sulfate Proteoglycans; Humans; Japan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Physostigmine; Polymorphism, Single Nucleotide; Prefrontal Cortex; Reserpine; Schizophrenia | 2010 |